Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Recent developments regarding human immunodeficiency virus infection and stroke.

Sen S, Rabinstein AA, Elkind MS, Powers WJ.

Cerebrovasc Dis. 2012;33(3):209-18. doi: 10.1159/000335300. Epub 2012 Jan 19. Review.

2.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
3.

Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.

Corral I, Quereda C, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL, Muriel A, Masjuán J, Alonso-de-Leciñana M, Moreno S.

Cerebrovasc Dis. 2009;27(6):559-63. doi: 10.1159/000214219. Epub 2009 Apr 24.

PMID:
19390181
4.

Human immunodeficiency virus (HIV) and stroke: targets for intervention.

Connor M.

Infect Disord Drug Targets. 2010 Apr;10(2):76-83. Review.

PMID:
20166974
5.

Stroke in HIV infection and AIDS.

Dobbs MR, Berger JR.

Expert Rev Cardiovasc Ther. 2009 Oct;7(10):1263-71. doi: 10.1586/erc.09.72. Review.

PMID:
19814669
6.

Antiretroviral therapy with heart.

Randell P, Moyle G.

Am J Ther. 2009 Nov-Dec;16(6):579-84. doi: 10.1097/MJT.0b013e318192116f. Review.

PMID:
19940610
7.

HIV infection, antiretroviral therapy and cardiovascular risk.

Barbaro G.

J Cardiovasc Risk. 2002 Oct;9(5):295-300. Review.

PMID:
12394324
8.

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group.

AIDS. 2003 May 23;17(8):1179-93.

PMID:
12819520
9.

Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.

Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Egger M, Weber R; Swiss HIV Cohort Study.

Clin Infect Dis. 2007 Jul 1;45(1):111-9. Epub 2007 May 21.

PMID:
17554711
10.

Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.

Kong HH, Myers SA.

Dermatol Ther. 2005 Jan-Feb;18(1):58-66. Review.

PMID:
15842613
11.

[Atherosclerosis in HIV-positive patients].

Neumann T, Miller M, Esser S, Gerken G, Erbel R.

Z Kardiol. 2002 Nov;91(11):879-88. Review. German.

PMID:
12442190
12.

Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa.

Hoffmann M, Berger JR, Nath A, Rayens M.

J Neurovirol. 2000 Jun;6(3):229-36.

PMID:
10878712
13.
14.

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA.

N Engl J Med. 2003 Feb 20;348(8):702-10.

15.

Human immunodeficiency virus and atherosclerosis.

Farrugia PM, Lucariello R, Coppola JT.

Cardiol Rev. 2009 Sep-Oct;17(5):211-5. doi: 10.1097/CRD.0b013e3181b151a3. Review.

PMID:
19690471
16.

HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.

Francisci D, Giannini S, Baldelli F, Leone M, Belfiori B, Guglielmini G, Malincarne L, Gresele P.

AIDS. 2009 Mar 13;23(5):589-96. doi: 10.1097/QAD.0b013e328325a87c.

PMID:
19177019
18.

Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.

Wu PY, Hung CC, Liu WC, Hsieh CY, Sun HY, Lu CL, Wu H, Chien KL.

J Antimicrob Chemother. 2012 Apr;67(4):1001-9. doi: 10.1093/jac/dkr558. Epub 2012 Jan 9.

PMID:
22232517
19.

Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.

Kwong GP, Ghani AC, Rode RA, Bartley LM, Cowling BJ, da Silva B, Donnelly CA, van Sighem AI, Cameron DW, Danner SA, de Wolf F, Anderson RM.

AIDS. 2006 Oct 3;20(15):1941-50.

PMID:
16988515
20.

Cerebrovascular disease in highly active antiretroviral therapy-treated individuals: incidence and risk factors.

Monforte Ad, Bongiovanni M.

J Neurovirol. 2005;11 Suppl 3:34-7. Review.

PMID:
16540453

Supplemental Content

Support Center